# Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?

> **NCT00817713** · NA · TERMINATED · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 295 (actual)

## Conditions studied

- HIV Infections
- Helminthiasis

## Interventions

- **DRUG:** Praziquantel, Ivermectin, Albendazole

## Key facts

- **NCT ID:** NCT00817713
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 295 (ACTUAL)
- **Why stopped:** Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.
- **Last updated:** 2011-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817713, "Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00817713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*